Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Viremia”

69 trials

Showing 20 of 69 results

Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableStudy completedNCT00000840
What this trial is testing

A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT04048629
What this trial is testing

Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in Zimbabwe

Who this might be right for
HIV Infections
Clinton Health Access Initiative Inc. 1,715
Post-approval studies (Phase 4)Study completedNCT02159599
What this trial is testing

Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject

Who this might be right for
HIV Infection
Fundacion SEIMC-GESIDA 249
Testing effectiveness (Phase 2)Ended earlyNCT02116660
What this trial is testing

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 11
Not applicableNot Yet RecruitingNCT07015164
What this trial is testing

Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral Therapy

Who this might be right for
HIV
Assistance Publique - Hôpitaux de Paris 80
Not applicableStudy completedNCT03088241
What this trial is testing

"Switch Either Near Suppression Or THOusand"

Who this might be right for
HIV/AIDS
Niklaus Labhardt 80
Testing effectiveness (Phase 2)Study completedNCT00000790
What this trial is testing

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

Who this might be right for
HIV InfectionsStomatitis, Aphthous
National Institute of Allergy and Infectious Diseases (NIAID) 164
Large-scale testing (Phase 3)WithdrawnNCT01605084
What this trial is testing

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Who this might be right for
HIV
Bristol-Myers Squibb
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Testing effectiveness (Phase 2)Study completedNCT00515827
What this trial is testing

Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Early research (Phase 1)Study completedNCT01378156
What this trial is testing

A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART

Who this might be right for
HIV-1 Infection
GeoVax, Inc. 9
Not applicableEnded earlyNCT05219916
What this trial is testing

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

Who this might be right for
Human Immunodeficiency Virus I Infection
Hospices Civils de Lyon 17
Not applicableStudy completedNCT00001110
What this trial is testing

Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Post-approval studies (Phase 4)Study completedNCT00966329
What this trial is testing

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Who this might be right for
HIVHIV Infections
Germans Trias i Pujol Hospital 30
Large-scale testing (Phase 3)Study completedNCT00160329
What this trial is testing

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Who this might be right for
HyperlipidemiaHIV Infections
Stanford University 60
Not applicableStudy completedNCT00867854
What this trial is testing

Treatment De-Intensification and Residual HIV-1 in Youth

Who this might be right for
HIV-1HIV Infections
University of North Carolina, Chapel Hill 34
Testing effectiveness (Phase 2)Study completedNCT01933594
What this trial is testing

Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 59
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation